Bluebird Bio Inc (BLUE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2017 | 06-2017 | 03-2017 | 12-2016 | 09-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 237,962 | 686,334 | 216,001 | 278,887 | 245,154 |
| Marketable Securities | 490,812 | 409,100 | 418,067 | 425,491 | 355,806 |
| Receivables | 2,712 | 4,334 | 21,228 | 8,542 | N/A |
| Other current assets | 13,328 | 3,814 | 3,285 | 3,085 | 0 |
| TOTAL | $758,707 | $1,118,618 | $667,311 | $724,214 | $608,835 |
| Non-Current Assets | |||||
| PPE Net | 182,358 | 180,419 | 181,720 | 156,955 | 131,737 |
| Investments And Advances | 413,856 | 101,625 | 165,801 | 180,452 | 126,681 |
| Intangibles | 31,000 | 31,940 | 32,881 | 33,822 | 34,762 |
| Other Non-Current Assets | 19,835 | 24,528 | 24,857 | 22,679 | 16,247 |
| TOTAL | $647,049 | $338,512 | $405,259 | $393,908 | $309,427 |
| Total Assets | $1,405,756 | $1,457,130 | $1,072,570 | $1,118,122 | $918,262 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 12,309 | 14,424 | 8,769 | 13,664 | 6,710 |
| Accrued Expenses | 42,595 | 43,748 | 44,307 | 54,660 | 54,672 |
| TOTAL | $76,801 | $77,838 | $72,636 | $74,533 | $67,591 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 21,897 | 19,666 | 19,560 | 6,209 | 6,209 |
| Other Non-Current Liabilities | 157,276 | 157,271 | 150,790 | 123,537 | 103,407 |
| TOTAL | $187,637 | $179,273 | $184,555 | $174,149 | $156,158 |
| Total Liabilities | $264,438 | $257,111 | $257,191 | $248,682 | $223,749 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,292 | 2,279 | 2,048 | 2,042 | 1,865 |
| Common Shares | 458 | 455 | 409 | 407 | 373 |
| Retained earnings | -796,580 | -717,775 | -646,876 | -577,674 | -506,310 |
| Other shareholders' equity | -2,097 | -1,415 | -1,252 | -1,149 | -836 |
| TOTAL | $1,141,318 | $1,200,019 | $815,379 | $869,440 | $694,513 |
| Total Liabilities And Equity | $1,405,756 | $1,457,130 | $1,072,570 | $1,118,122 | $918,262 |